Heffernan AJ - Search Results

1

Host Diagnostic Biomarkers of Infection in the ICU: Where Are We and Where Are We Going?

Heffernan AJ, Denny KJ. Heffernan AJ, et al. Curr Infect Dis Rep. 2021;23(4):4. doi: 10.1007/s11908-021-00747-0. Epub 2021 Feb 12. Curr Infect Dis Rep. 2021. PMID: 33613126 Free PMC article. Review.

2

Ceftriaxone dosing in patients admitted from the emergency department with sepsis.

Heffernan AJ, Curran RA, Denny KJ, Sime FB, Stanford CL, McWhinney B, Ungerer J, Roberts JA, Lipman J. Heffernan AJ, et al. Eur J Clin Pharmacol. 2021 Feb;77(2):207-214. doi: 10.1007/s00228-020-03001-z. Epub 2020 Sep 24. Eur J Clin Pharmacol. 2021. PMID: 32974748

3

Diagnosing sepsis in the ICU: Comparison of a gene expression signature to pre-existing biomarkers.

Denny KJ, Lea RA, Lindell-Innes R, Haupt LM, Heffernan AJ, Harvey NR, Hughes O, Cao VT, Stuart J, Paterson DL, McNamara JF, Ungerer JPJ, Pretorius CJ, Griffiths LR, Lipman J. Denny KJ, et al. Among authors: heffernan aj. J Crit Care. 2023 Aug;76:154286. doi: 10.1016/j.jcrc.2023.154286. Epub 2023 Mar 23. J Crit Care. 2023. PMID: 36965223 Free article.

4

How to optimize antibiotic pharmacokinetic/pharmacodynamics for Gram-negative infections in critically ill patients.

Heffernan AJ, Sime FB, Taccone FS, Roberts JA. Heffernan AJ, et al. Curr Opin Infect Dis. 2018 Dec;31(6):555-565. doi: 10.1097/QCO.0000000000000494. Curr Opin Infect Dis. 2018. PMID: 30299354 Review.

5

Pharmacodynamics of once- versus twice-daily dosing of nebulized amikacin in an in vitro Hollow-Fiber Infection Model against 3 clinical isolates of Pseudomonas aeruginosa.

Heffernan AJ, Sime FB, Naicker S, Andrews K, Ellwood D, Guerra-Valero Y, Wallis S, Lipman J, Grimwood K, Roberts JA. Heffernan AJ, et al. Diagn Microbiol Infect Dis. 2021 Jun;100(2):115329. doi: 10.1016/j.diagmicrobio.2021.115329. Epub 2021 Feb 6. Diagn Microbiol Infect Dis. 2021. PMID: 33714790

6

Dose optimisation of antibiotics used for meningitis.

Heffernan AJ, Roberts JA. Heffernan AJ, et al. Curr Opin Infect Dis. 2021 Dec 1;34(6):581-590. doi: 10.1097/QCO.0000000000000783. Curr Opin Infect Dis. 2021. PMID: 34534985 Review.

7

Individualising Therapy to Minimize Bacterial Multidrug Resistance.

Heffernan AJ, Sime FB, Lipman J, Roberts JA. Heffernan AJ, et al. Drugs. 2018 Apr;78(6):621-641. doi: 10.1007/s40265-018-0891-9. Drugs. 2018. PMID: 29569104 Review.

8

Vancomycin population pharmacokinetics for adult patients with sepsis or septic shock: are current dosing regimens sufficient?

Heffernan AJ, Germano A, Sime FB, Roberts JA, Kimura E. Heffernan AJ, et al. Eur J Clin Pharmacol. 2019 Sep;75(9):1219-1226. doi: 10.1007/s00228-019-02694-1. Epub 2019 Jun 1. Eur J Clin Pharmacol. 2019. PMID: 31154476

9

A personalised approach to antibiotic pharmacokinetics and pharmacodynamics in critically ill patients.

Heffernan AJ, Mohd Sazlly Lim S, Lipman J, Roberts JA. Heffernan AJ, et al. Anaesth Crit Care Pain Med. 2021 Dec;40(6):100970. doi: 10.1016/j.accpm.2021.100970. Epub 2021 Oct 30. Anaesth Crit Care Pain Med. 2021. PMID: 34728411 Review.

10

Evaluating Mono- and Combination Therapy of Meropenem and Amikacin against Pseudomonas aeruginosa Bacteremia in the Hollow-Fiber Infection Model.

Avent ML, McCarthy KL, Sime FB, Naicker S, Heffernan AJ, Wallis SC, Paterson DL, Roberts JA. Avent ML, et al. Among authors: heffernan aj. Microbiol Spectr. 2022 Jun 29;10(3):e0052522. doi: 10.1128/spectrum.00525-22. Epub 2022 Apr 20. Microbiol Spectr. 2022. PMID: 35442072 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

41 results

Search Page